News
ProKidney Corp. (PROK) shares just saw a massive green day. Results from Phase 2 were compelling and the data sharply ...
US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...
18h
Zacks.com on MSNPROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy StudyShares of ProKidney Corp. PROK skyrocketed 515% yesterday after the company reported encouraging top-line data from the phase ...
ProKidney shares are trading sharply higher Wednesday morning. The stock is gaining following a marked surge on Tuesday ...
WK Kellogg shares jumped 50.2% to $26.31 in the pre-market trading session. Here are some other stocks moving in pre-market ...
Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond ...
Researchers at the Chinese Academy of Sciences and collaborators have developed a new method to label and monitor dormant breast cancer cells over time, shedding light on how these cells survive ...
In the second largest M&A deal of the year, Merck & Co. Inc. has strengthened its cardiopulmonary portfolio with the $10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results